{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T20:38:52Z","timestamp":1776458332568,"version":"3.51.2"},"publisher-location":"Totowa, NJ","reference-count":66,"publisher":"Humana Press","isbn-type":[{"value":"9781607617198","type":"print"},{"value":"9781607617204","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-60761-720-4_20","type":"book-chapter","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T19:47:46Z","timestamp":1354304866000},"page":"403-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pathogenesis of Multiple Sclerosis: What Can We Learn from the Cuprizone Model"],"prefix":"10.1007","author":[{"given":"Peter","family":"Acs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"Kalman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,13]]},"reference":[{"issue":"3","key":"20_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/WNF.0b013e3181880359","volume":"32","author":"JL Bennett","year":"2009","unstructured":"Bennett JL, St\u00fcve O (2009) Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications. Clin Neuropharmacol 32(3):121\u2013132","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"20_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0008-8749(82)90457-9","volume":"73","author":"DS Linthicum","year":"1982","unstructured":"Linthicum DS, Munoz JJ, Blaskett A (1982) Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell Immunol 73(2):299\u2013310","journal-title":"Cell Immunol"},{"issue":"2","key":"20_CR3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0022-3565(25)39127-5","volume":"242","author":"ME Westarp","year":"1987","unstructured":"Westarp ME, Wekerle H, Ben-Nun A et al (1987) T lymphocyte line-mediated experimental allergic encephalomyelitis \u2013 a pharmacologic model for testing of immunosuppressive agents for the treatment of autoimmune central nervous system disease. J Pharmacol Exp Ther 242(2):614\u2013620","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"20_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ni.1803","volume":"11","author":"L Steinman","year":"2010","unstructured":"Steinman L (2010) Mixed results with modulation of TH-17 cells in human autoimmune diseases. Nat Immunol 11(1):41\u201344","journal-title":"Nat Immunol"},{"issue":"2","key":"20_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1365-2249.2009.04037.x","volume":"159","author":"SQ Crome","year":"2010","unstructured":"Crome SQ, Wang AY, Levings MK (2010) Translational mini-review series on TH17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 159(2):109\u2013119","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"20_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2249.2009.04040.x","volume":"159","author":"RA O'Connor","year":"2010","unstructured":"O\u2019Connor RA, Taams LS, Anderton SM (2010) Translational mini-review series on Th17 cells: CD4 T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation. Clin Exp Immunol 159(2):137\u2013147","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"20_CR7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.21944","volume":"67","author":"J Correale","year":"2010","unstructured":"Correale J, Villa A (2010) Role of regulatory CD8+CD25+FoxP3+ T cells in multiple sclerosis. Ann Neurol 67(5):625\u2013638","journal-title":"Ann Neurol"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/brain\/awh486","volume":"128","author":"S Cepok","year":"2005","unstructured":"Cepok S, Rosche B, Grummel V et al (2005) Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 128:1667\u20131676","journal-title":"Brain"},{"key":"20_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1172\/JCI3568","volume":"102","author":"Y Qin","year":"1998","unstructured":"Qin Y, Duquette P, Zhang Y et al (1998) Clonal expansion and somatic hypermutation of Vh genes of B cells from the cerebrospinal fluid in multiple sclerosis. J Clin Invest 102:1045\u20131050","journal-title":"J Clin Invest"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1006\/clim.2000.4967","volume":"98","author":"GP Owens","year":"2001","unstructured":"Owens GP, Burgoon MP, Anthony J et al (2001) The immunoglobulin G heavy chain repertoire in multiple sclerosis plaques is distinct from the heavy chain repertoire in peripheral blood lymphocytes. Clin Immunol 98:258\u2013263","journal-title":"Clin Immunol"},{"issue":"1\u20132","key":"20_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jneuroim.2004.04.022","volume":"158","author":"NL Monson","year":"2005","unstructured":"Monson NL, Brezinschek HP, Brezinschek RI et al (2005) Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients. J Neuroimmunol 158(1\u20132):170\u2013181","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"20_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jneuroim.2007.03.002","volume":"186","author":"D Lambracht-Washington","year":"2007","unstructured":"Lambracht-Washington D, O\u2019Connor KC, Cameron EM et al (2007) Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS. J Neuroimmunol 186(1\u20132):164\u2013176","journal-title":"J Neuroimmunol"},{"issue":"2","key":"20_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","volume":"14","author":"B Serafini","year":"2004","unstructured":"Serafini B, Rosicarelli B, Magliozzi R et al (2004) Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14(2):164\u2013174","journal-title":"Brain Pathol"},{"issue":"Pt 12","key":"20_CR14","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1093\/brain\/awp200","volume":"132","author":"SN Willis","year":"2009","unstructured":"Willis SN, Stadelmann C, Rodig SJ et al (2009) Epstein\u2013Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 132(Pt 12):3318\u20133328","journal-title":"Brain"},{"issue":"3","key":"20_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00019052-200106000-00002","volume":"14","author":"C Lucchinetti","year":"2001","unstructured":"Lucchinetti C, Br\u00fcck W, Noseworthy J (2001) Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Curr Opin Neurol 14(3):259\u2013269","journal-title":"Curr Opin Neurol"},{"key":"20_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/400_2009_22","volume":"51","author":"C Stoeckle","year":"2009","unstructured":"Stoeckle C, Tolosa E (2009) Antigen processing and presentation in multiple sclerosis. Results Probl Cell Differ 2010;51:149\u2013172","journal-title":"Results Probl Cell Differ"},{"issue":"10","key":"20_CR17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1212\/01.wnl.0000320512.21919.d2","volume":"71","author":"DS Goodin","year":"2008","unstructured":"Goodin DS, Cohen BA, O\u2019Connor P et al (2008) Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 71(10):766\u2013773","journal-title":"Neurology"},{"issue":"7","key":"20_CR18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","volume":"358","author":"SL Hauser","year":"2008","unstructured":"Hauser SL, Waubant E, Arnold DL et al (2008) HERMES Trial Group. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 358(7):676\u2013688","journal-title":"N Engl J Med"},{"issue":"3","key":"20_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ana.21363","volume":"63","author":"A Bar-Or","year":"2008","unstructured":"Bar-Or A, Calabresi PA, Arnold D et al (2008) Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann Neurol 63(3):395\u2013400","journal-title":"Ann Neurol"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"BD Trapp","year":"1998","unstructured":"Trapp BD, Peterson J, Ransohoff RM et al (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278\u2013285","journal-title":"N Engl J Med"},{"key":"20_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0165-5728(99)00081-8","volume":"98","author":"BD Trapp","year":"1999","unstructured":"Trapp BD, Bo L, Mork S, Chang A (1999) Pathogenesis of tissue injury in MS lesions. J Neuroimmunol 98:49\u201356","journal-title":"J Neuroimmunol"},{"key":"20_CR22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jnen\/61.6.539","volume":"61","author":"JW Peterson","year":"2002","unstructured":"Peterson JW, Bo L, Mork S, Chang A et al (2002) VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions. J Neuropathol Exp Neurol 61:539\u2013546","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 11","key":"20_CR23","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/brain\/awh641","volume":"128","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg A, Lucchinetti CF, Stadelmann C (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128(Pt 11):2705\u20132712","journal-title":"Brain"},{"issue":"6","key":"20_CR24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Br\u00fcck W, Parisi J et al (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47(6):707\u2013717","journal-title":"Ann Neurol"},{"key":"20_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ana.20016","volume":"55","author":"MH Barnett","year":"2004","unstructured":"Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458\u2013468","journal-title":"Ann Neurol"},{"key":"20_CR26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/ana.21800","volume":"66","author":"AP Henderson","year":"2009","unstructured":"Henderson AP, Barnett MH, Parratt JD, Prineas JW et al (2009) Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol 66:739\u2013753","journal-title":"Ann Neurol"},{"key":"20_CR27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/01.wco.0000227032.47458.cb","volume":"19","author":"MH Barnett","year":"2006","unstructured":"Barnett MH, Sutton I (2006) The pathology of multiple sclerosis: a paradigm shift. Curr Opin Neurol 19:242\u2013247","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"20_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ana.21311","volume":"63","author":"EC Breij","year":"2008","unstructured":"Breij EC, Brink BP, Veerhuis R et al (2008) Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 63(1):16\u201325","journal-title":"Ann Neurol"},{"key":"20_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.1123","volume":"50","author":"JW Peterson","year":"2001","unstructured":"Peterson JW, Bo L, Mork S et al (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389\u2013400","journal-title":"Ann Neurol"},{"key":"20_CR30","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/01.jnen.0000190067.20935.42","volume":"64","author":"M Vercellino","year":"2005","unstructured":"Vercellino M, Plano F, Votta B et al (2005) Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 64:1101\u20131107","journal-title":"J Neuropathol Exp Neurol"},{"key":"20_CR31","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1212\/01.wnl.0000237551.26858.39","volume":"67","author":"C Wegener","year":"2006","unstructured":"Wegener C, Esiri MM, Chance SA et al (2006) Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 67:960\u2013967","journal-title":"Neurology"},{"issue":"1","key":"20_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s004410000179","volume":"301","author":"F Zipp","year":"2000","unstructured":"Zipp F (2000) Apoptosis in multiple sclerosis. Cell Tissue Res 301(1):163\u2013171","journal-title":"Cell Tissue Res"},{"issue":"2","key":"20_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jaut.2009.01.004","volume":"32","author":"AL Hestvik","year":"2009","unstructured":"Hestvik AL, Skorstad G, Vartdal F et al (2009) Idiotype-specific CD4+ T cell induced apoptosis of human oligodendrocytes. J Autoimmun 32(2):125\u2013132","journal-title":"J Autoimmun"},{"key":"20_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0022-510X(00)00343-9","volume":"177","author":"F Lu","year":"2000","unstructured":"Lu F, Selak M, O\u2019Connor J et al (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in lesions of multiple sclerosis. J Neurol Sci 177:95\u2013103","journal-title":"J Neurol Sci"},{"issue":"4","key":"20_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/08916930290005611","volume":"35","author":"B Kalman","year":"2002","unstructured":"Kalman B, Albert RH, Leist TP (2002) Genetics of multiple sclerosis: determinants of autoimmunity and neurodegeneration. Autoimmunity 35(4):225\u2013234","journal-title":"Autoimmunity"},{"issue":"1\u20132","key":"20_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2007.03.020","volume":"188","author":"B Kalman","year":"2007","unstructured":"Kalman B, Laitinen K, Komoly S (2007) The involvement of mitochondria in the pathogenesis of multiple sclerosis. J Neuroimmunol 188(1\u20132):1\u201312","journal-title":"J Neuroimmunol"},{"key":"20_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s11910-006-0012-0","volume":"6","author":"B Kalman","year":"2006","unstructured":"Kalman B (2006) Role of Mitochondria in MS. Curr Neurol Neurosci Rep 6:244\u2013252","journal-title":"Curr Neurol Neurosci Rep"},{"key":"20_CR38","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ana.410360515","volume":"36","author":"L Bo","year":"1994","unstructured":"Bo L, Dawson TM, Wesselingh S et al (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36:778\u2013786","journal-title":"Ann Neurol"},{"key":"20_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0165-5728(97)00145-8","volume":"80","author":"AH Cross","year":"1997","unstructured":"Cross AH, Manning PT, Stern MK et al (1997) Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J Neuroimmunol 80:121\u2013130","journal-title":"J Neuroimmunol"},{"key":"20_CR40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/135245859800400503","volume":"4","author":"O Vladimirova","year":"1998","unstructured":"Vladimirova O, O\u2019Connor J, Cahill A et al (1998) Oxidative damage to DNA in plaques of MS brains. Mult Scler 4:413\u2013418","journal-title":"Mult Scler"},{"key":"20_CR41","first-page":"1544","volume":"13","author":"T Powell","year":"1992","unstructured":"Powell T, Sussman JG, Davies-Jones GA (1992) MR imaging in acute multiple sclerosis: ringlike appearance in plaques suggesting the presence of paramagnetic free radicals. Am J Neurorad 13:1544\u20131546","journal-title":"Am J Neurorad"},{"key":"20_CR42","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1073\/pnas.94.6.2528","volume":"94","author":"DC Hooper","year":"1997","unstructured":"Hooper DC, Bagasra O, Marini JC et al (1997) Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxinitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci 94:2528\u20132533","journal-title":"Proc Natl Acad Sci"},{"key":"20_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12017-008-8025-2","volume":"10","author":"A Blokhin","year":"2008","unstructured":"Blokhin A, Vyshkina T, Komoly S et al (2008) Lack of mitochondrial DNA deletions in lesion of multiple sclerosis. Neuromolecular Med 10:187\u2013194","journal-title":"Neuromolecular Med"},{"key":"20_CR44","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ana.20736","volume":"59","author":"R Dutta","year":"2006","unstructured":"Dutta R, McDonough J, Yin X et al (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59:478\u2013489","journal-title":"Ann Neurol"},{"issue":"6","key":"20_CR45","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1365-2990.2008.00987.x","volume":"34","author":"D Mahad","year":"2008","unstructured":"Mahad D, Lassmann H, Turnbull D (2008) Review: mitochondria and disease progression in multiple sclerosis. Neuropathol Appl Neurobiol 34(6):577\u2013589","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"Pt 5","key":"20_CR46","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/brain\/awp046","volume":"132","author":"DJ Mahad","year":"2009","unstructured":"Mahad DJ, Ziabreva I, Campbell G et al (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132(Pt 5):1161\u20131174","journal-title":"Brain"},{"issue":"Pt 7","key":"20_CR47","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/brain\/awn105","volume":"131","author":"D Mahad","year":"2008","unstructured":"Mahad D, Ziabreva I, Lassmann H et al (2008) Mitochondrial defects in acute multiple sclerosis lesions. Brain 131(Pt 7):1722\u20131735","journal-title":"Brain"},{"key":"20_CR48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S1474-4422(09)70043-2","volume":"8","author":"BD Trapp","year":"2009","unstructured":"Trapp BD, Stys PK (2009) Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Review. Lancet Neurol 8:280\u2013291","journal-title":"Lancet Neurol"},{"key":"20_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-004-0954-8","volume":"109","author":"F Aboul-Enein","year":"2005","unstructured":"Aboul-Enein F, Lassmann H (2005) Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? Acta Neuropathol (Berl) 109:49\u201355","journal-title":"Acta Neuropathol (Berl)."},{"key":"20_CR50","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/brain\/awh457","volume":"128","author":"C Stadelmann","year":"2005","unstructured":"Stadelmann C, Ludwin S, Tabira T et al (2005) Tissue preconditioning may explain concentric lesions in Balo\u2019s type of multiple sclerosis. Brain 128:979\u2013987","journal-title":"Brain"},{"key":"20_CR51","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1750-3639.2003.tb00485.x","volume":"13","author":"U Graumann","year":"2003","unstructured":"Graumann U, Reynolds R, Steck AJ et al (2003) Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol 13:554\u2013573","journal-title":"Brain Pathol"},{"key":"20_CR52","first-page":"597","volume":"39","author":"SK Ludwin","year":"1978","unstructured":"Ludwin SK (1978) Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab Invest 39:597\u2013612","journal-title":"Lab Invest"},{"key":"20_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","volume":"11","author":"GK Matsushima","year":"2001","unstructured":"Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107\u2013116","journal-title":"Brain Pathol"},{"key":"20_CR54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neulet.2009.02.004","volume":"453","author":"M Lindner","year":"2009","unstructured":"Lindner M, Fokuhl J, Linsmeier F et al (2009) Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination. Neurosci Lett 453:120\u2013125","journal-title":"Neurosci Lett"},{"key":"20_CR55","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/brain\/awp337","volume":"133","author":"S Veto","year":"2010","unstructured":"Veto S, Acs P, Bauer J et al (2010) Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death. Brain 133:822\u2013834","journal-title":"Brain"},{"key":"20_CR56","first-page":"40","volume":"58","author":"S Komoly","year":"2005","unstructured":"Komoly S (2005) Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected]. Ideggyogy Sz 58:40\u201343","journal-title":"Ideggyogy Sz"},{"key":"20_CR57","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","volume":"118","author":"M Kipp","year":"2009","unstructured":"Kipp M, Clarner T, Dang J (2009) The cuprizone animal model: new insights into an old story. Acta Neuropathol 118:723\u2013736","journal-title":"Acta Neuropathol"},{"issue":"5","key":"20_CR58","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2353\/ajpath.2007.060783","volume":"170","author":"LT Remington","year":"2007","unstructured":"Remington LT, Babcock AA, Zehntner SP et al (2007) Microglial recruitment, activation, and proliferation in response to primary demyelination. Am J Pathol 170(5):1713\u20131724","journal-title":"Am J Pathol"},{"key":"20_CR59","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11064-006-9165-0","volume":"32","author":"LA Pasquini","year":"2007","unstructured":"Pasquini LA, Calatayud CA, Bertone Una AL et al (2007) The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem Res 32:279\u2013292","journal-title":"Neurochem Res"},{"key":"20_CR60","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/glia.20806","volume":"57","author":"P Acs","year":"2009","unstructured":"Acs P, Kipp M, Norkute A et al (2009) 17b-Estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 57:807\u2013814","journal-title":"Glia"},{"key":"20_CR61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2990.2007.00879.x","volume":"34","author":"M Lindner","year":"2008","unstructured":"Lindner M, Heine S, Haastert K et al (2008) Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol Appl Neurobiol 34:105\u2013114","journal-title":"Neuropathol Appl Neurobiol"},{"key":"20_CR62","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2217\/14796708.2.6.689","volume":"2","author":"RC Armstrong","year":"2007","unstructured":"Armstrong RC (2007) Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS. Future Neurol 2:689\u2013697","journal-title":"Future Neurol"},{"key":"20_CR63","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1006\/mcne.1998.0715","volume":"12","author":"P Morell","year":"1998","unstructured":"Morell P, Barrett CV, Mason JL et al (1998) Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol Cell Neurosci 12:220\u2013227","journal-title":"Mol Cell Neurosci"},{"key":"20_CR64","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1750-3639.2008.00230.x","volume":"19","author":"LC Taylor","year":"2009","unstructured":"Taylor LC, Gilmore W, Matsushima GK (2009) SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination. Brain Pathol 19:467\u2013479","journal-title":"Brain Pathol"},{"key":"20_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0165-5728(98)00168-4","volume":"92","author":"MM Hiremath","year":"1998","unstructured":"Hiremath MM, Saito Y, Knapp GW et al (1998) Microglial\/macrophage accumulation during cuprizone-induced demyelination in C57BL\/6 mice. J Neuroimmunol 92:38\u201349","journal-title":"J Neuroimmunol"},{"key":"20_CR66","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0076-6879(83)03025-6","volume":"103","author":"M Palkovits","year":"1983","unstructured":"Palkovits M (1983) Punch sampling biopsy technique. Methods Enzymol 103:368\u2013376","journal-title":"Methods Enzymol"}],"container-title":["Methods in Molecular Biology","Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-60761-720-4_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:46:04Z","timestamp":1745369164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-60761-720-4_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9781607617198","9781607617204"],"references-count":66,"URL":"https:\/\/doi.org\/10.1007\/978-1-60761-720-4_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"13 July 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}